Magnus Financial Group LLC Has $1.46 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Magnus Financial Group LLC cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 9.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,719 shares of the financial services provider’s stock after selling 1,121 shares during the period. Magnus Financial Group LLC’s holdings in iShares Biotechnology ETF were worth $1,456,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Glass Jacobson Investment Advisors llc raised its stake in shares of iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after buying an additional 122 shares during the last quarter. Values First Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $43,000. Horizon Bancorp Inc. IN acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at $44,000. Tennessee Valley Asset Management Partners bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $44,000. Finally, Column Capital Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the third quarter worth $49,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.7 %

NASDAQ IBB traded up $0.82 on Friday, reaching $126.49. The company had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The stock’s 50 day moving average is $134.27 and its 200-day moving average is $129.74.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.40%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.